In the Phase 3 ATTAIN-1 trial published in the New England Journal of Medicine in 2025, once-daily orforglipron produced mean body weight reductions of 7.5% (6 mg), 8.4% (12 mg), and 11.2% (36 mg) at 72 weeks, compared with 2.1% for placebo
Localized wound healing studies typically use every-48-hour dosing for 1421 days, while systemic collagen synthesis protocols use every-72-hour dosing for 2128 days
(You can actually try it yourself if youre one of the lucky ones to snag this weeks BeautyPass Free Gift Friday
Its okay to leave food on your plate if youre done dont force yourself to finish just because its a special food
Troubleshooting: Clumps, Cloudiness, Particles Clumpy or slow to dissolve: give it more time and keep swirling gently resist the urge to shake
Optimal needling protocols Needle depth affects results significantly